IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Public ClinicalTrials.gov record NCT06112314. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants With Previously Untreated Advanced Melanoma (PRISM-MEL-301
Study identification
- NCT ID
- NCT06112314
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Immunocore Ltd
- Industry
- Enrollment
- 680 participants
Conditions and interventions
Conditions
Interventions
- Brenetafusp Drug
- Nivolumab Drug
- Nivolumab + Relatlimab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 4, 2024
- Primary completion
- Oct 15, 2027
- Completion
- Oct 15, 2027
- Last update posted
- Feb 24, 2026
2024 – 2027
United States locations
- U.S. sites
- 37
- U.S. states
- 23
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona | Tucson | Arizona | 85720 | Recruiting |
| University of California - San Diego | La Jolla | California | 92093-0698 | Recruiting |
| The Angeles Clinic and Research Institute- West Los Angeles | Los Angeles | California | 90025 | Recruiting |
| ESC Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Recruiting |
| UCLA Hematology/Oncology | Los Angeles | California | 90095 | Recruiting |
| Stanford Cancer Institute - Stanford Cancer Center Palo Alto | Palo Alto | California | 94304 | Completed |
| Saint John's Health Center - John Wayne Cancer Institute (JWCI) | Santa Monica | California | 90404 | Recruiting |
| University of Colorado, Anschutz Medical Campus | Aurora | Colorado | 80045 | Recruiting |
| The Melanoma & Skin Cancer Institute | Denver | Colorado | 80222 | Recruiting |
| UConn Health-Farmington (University of Connecticut Health Center (UCHC)) | Farmington | Connecticut | 06030-2205 | Completed |
| Georgetown University | Washington D.C. | District of Columbia | 20007 | Recruiting |
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | Recruiting |
| University of Miami Health System-Sylvester Comprehensive Cancer Center-Miami | Miami | Florida | 33136 | Recruiting |
| Northwestern University - Robert H. Lurie Comprehensive Cancer Center - NMDTI | Chicago | Illinois | 60611 | Recruiting |
| The University of Kansas Cancer Center (KUCC) - Westwood | Westwood | Kansas | 66205 | Recruiting |
| St. Elizabeth Healthcare - Edgewood | Edgewood | Kentucky | 41017 | Recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | Recruiting |
| Henry Ford Cancer Center - Michigan | Detroit | Michigan | 04820 | Recruiting |
| Allina Health Cancer Institute - Minneapolis | Minneapolis | Minnesota | 55407 | Recruiting |
| Washington University School of Medicine | St Louis | Missouri | 63110 | Completed |
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack | New Jersey | 07601 | Recruiting |
| Northwell Health Cancer Institute | Lake Success | New York | 11042 | Recruiting |
| Columbia University Medical Center | New York | New York | 10032 | Completed |
| The Ohio State University | Columbus | Ohio | 43210 | Recruiting |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | Recruiting |
| UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | Recruiting |
| Prisma Health Cancer Institute | Greenville | South Carolina | 29605 | Recruiting |
| Spartanburg Regional Healthcare System - Spartanburg Medical Center (SMC) | Spartanburg | South Carolina | 29303 | Recruiting |
| The University of Tennessee - Knoxville (UTK) | Knoxville | Tennessee | 37920 | Recruiting |
| Sarah Cannon Research Institute: USA/TN | Nashville | Tennessee | 37203 | Recruiting |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | Recruiting |
| University of Texas Southwestern | Dallas | Texas | 75235-9179 | Recruiting |
| University of Utah Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | Recruiting |
| UVA Health-UVA Emily Couric Clinical Cancer Center | Charlottesville | Virginia | 22903 | Recruiting |
| Virginia Commonwealth University (VCU) - Massey Cancer Center | Richmond | Virginia | 23298-0070 | Recruiting |
| Swedish Medical Center - Swedish Cancer Institute (SCI) - First Hill Campus | Seattle | Washington | 98104 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 174 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06112314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2026 · Synced Jul 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06112314 live on ClinicalTrials.gov.